Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

ves of women with advanced breast cancer.

"Researching new cancer treatments is a complex step by step process. Each success helps lay the foundation for the next step forward," said William M. Burns, CEO Division Roche Pharmaceuticals. "These results show that we are making significant progress towards giving doctors and their breast cancer

patients better and more effective treatment options to fight this devastating disease at all stages," he added.

    Presentation of Data

    Herceptin

    Gianni L et al  Neoadjuvant trastuzumab in patients with   Friday 12th,
                    HER2-positive locally advanced breast      December
                    cancer: primary efficacy analysis of the   09:30 hrs
                    NOAH trial                                 General
                                                               Session 3
                                                               (Hall D)

    Xeloda

    Joensuu H et    Significant improvement in                 Sunday 14th,
    al. for The     recurrence-free survival (RFS)             December
    Finnish Breast  when capecitabine (X) is                   11:45 hrs
    Cancer Group    integrated into docetaxel (T)              General
                    5-FU + epirubicin + cyclophosphamide       Session 7
                    (CEF) adjuvant therapy for high-risk
                    early breast cancer (BC): interim
                    analysis of the FinXX-trial.

    Avastin

    Smith IE et al  Primary analysis of study MO19391, an      Saturday
                    open-label safety study of bevacizumab     13th,
                    plus taxane-based therapy as 1st-line      December
                    treatment of patients with locally         07:00 hrs
                    recurrent or metastatic breast cancer.     Poster
                                                               Session 4

'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... DIEGO , Nov. 26, 2014  Aethlon Medical, ... a definitive agreement to raise approximately $3.3 million at ... being made by one institutional healthcare focused investor. Each unit ... of a common share purchase warrant. Each whole warrant ... a price of $0.30 for a period of five ...
(Date:11/26/2014)... 2014 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... previously announced concurrent financing transactions resulting in gross ... offering expenses, Lexicon anticipates net proceeds of approximately ... of: , a public offering of ... registration statement that has been declared effective by ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
(Date:11/26/2014)... 27, 2014 Norwalk Hospital is ... Excellence® designation by the American Nurses Credentialing Center ... the elements of work environments where nurses can ... nurses at Norwalk Hospital and identifies it as ... It identifies an organizations’ commitment to nurses and ...
(Date:11/26/2014)... teens have stronger language and reading skills if their hearing ... suggests. Researchers looked at a group of deaf children ... an infant screening program conducted in the 1990s. A ... who were screened by the time they were 9 months ... who weren,t screened as infants. This new study assessed ...
(Date:11/26/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- When ... factor high altitude into your vacation sports -- ... specialist cautions. Outdoor explorers may fail ... recreation areas, which puts them at risk of ... high above sea level, according to Dr. Melissa ...
(Date:11/26/2014)... New regulations to reduce emissions of the smog-causing pollutant ... by the U.S. Environmental Protection Agency. Ozone has ... The new rules would lower the current limit ... between 65 to 70 parts per billion, the EPA ... the latest science will clean up our air, improve ...
(Date:11/26/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... smoking cigarettes than ever, health officials said. In fact, ... percent in 2005 to 18 percent in 2013. That means ... 42.1 million, despite the increasing population, according to the U.S. ... still have a long way to go, and if we ...
Breaking Medicine News(10 mins):Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2Health News:Don't Let High Altitude Ruin Your Holiday Trip 2Health News:EPA Issues Tougher Rules on Ozone Emissions 2Health News:EPA Issues Tougher Rules on Ozone Emissions 3Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 2Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 3
... ePrescribe program saves time, reduces costs and increases safety; $1000 incentive ... ... Chapel Hill, NC (PRWEB) July 22, 2008 -- Imagine a ... patient's prescription into a PDA or computer, and getting immediate feedback ...
... body, they could lead to nonsurgical treatments , , TUESDAY, July ... valuable in efforts to develop nonsurgical treatments for spinal cord ... and Sweden. , They say it may be possible to ... to repair damaged nerve cells. , An adult,s spinal cord ...
... minimally invasive treatment for a common cause of male infertility ... a new study published in the August issue of Radiology. ... also found that the level of sperm motility prior to ... embolization, a simple treatment using a catheter through the groin, ...
... samples in study of this pregnancy complication , , MONDAY, ... 10,000 people to participate in the world,s largest study ... The study will include 5,000 people from families with ... Researchers will collect genetic samples by taking cheek swabs ...
... University Medical Center appear to have solved at least a ... why so many patients with asthma also suffer from ... relationship between the two diseases in the mid-1970s. Since then, ... of patients with asthma experience some aspect of GERD. ...
... question of whether insulin-producing cells of the pancreas can ... to the further development of regenerative therapies against the ... (MUHC) and McGill University together with Dr Bernard Massie ... have just concluded that they can. The results of ...
Cached Medicine News:Health News:BCBSNC Makes Electronic Prescribing Available Statewide 2Health News:BCBSNC Makes Electronic Prescribing Available Statewide 3Health News:BCBSNC Makes Electronic Prescribing Available Statewide 4Health News:Spinal Cord Stem Cells May Act as Nerve Repair System 2Health News:Minimally invasive treatment improves male fertility 2Health News:Australian Study Seeks Genetic Roots of Cerebral Palsy 2Health News:Scientists identify how gastric reflux may trigger asthma 2Health News:Montreal researchers prove that insulin-producing cells can give rise to stem-like cells in-vitro 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: